More on belligerent trans-promoter Doctor Jack Turban:

Jack Turban, insistent critic of Abigail Shrier’s book on transitioning of young girls, constantly claims puberty blockers are safe. He is paid by a firm that manufactures them.

Jack Turban, MDfellow in child and adolescent psychiatry at Stanford University School of medicine, bills himself as an Allopathic & Osteopathic Physician. But he’s famous for his advocacy for certain positions regarding transgender medicine – for advocating for the ‘Gender Affirming Care for Trans and ‘gender-diverse’ youth’ as part of his work on ‘Pediatric Gender Identity’ and vigorously advocating for, and downplaying the risks of medical transition, while selling books on the same.

Suitably inflammatory and triggering, Turban’s shown himself to be quite willing to tag any questioning of the ‘affirmative’ model as ‘conversion therapy’ that will certainly lead to suicide and follows it up with smears of anyone questioning his rhetoric as ‘right wing bigots’ – that tried and tested strategy of any activist seeking to shut down conversation.

According to Open Payments Search Tool used to track payments made by drug and medical device companies to physicians and teaching hospitals, Jack Turban has received at least  $15,000 (US) from Arbor Pharmaceuticals, manufacturers of Triptodur™, (triptorelin) which, through extended release injectable suspension, has been shown to arrest or reverse the clinical signs of puberty, in cases of precocious puberty – the exact purpose Arbor advocates Triptodur for.

How interesting, and how very convenient. A physician insistently promoting the ‘benefits’ of puberty blockers, who repeatedly insists on their safety and who seemingly has endless amounts of time to attack, denigrate, and smear doctors who disagree, has at least a 15,000 USD incentive to sanitize and push a drug, paid directly by the manufacturers. 

5 Responses to “Incentive”